3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Completed
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Conditions
Polycystic Ovary Syndrome
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Recurrence
1
Multiple Myeloma
1
Leukemia, Myeloid, Chronic-Phase
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Imatinib Mesylate
17
Dasatinib
8
nilotinib
7
Cytarabine
5
Hydroxyurea
4
ponatinib
3
Peripheral Blood Stem Cell Transplantation
3
Interferon-alpha
3
bosutinib
2
Surveys and Questionnaires
2
Stem Cell Transplantation
2
Radiotherapy
2
Polymerase Chain Reaction
2
Pioglitazone
2
Idarubicin
2
Cytogenetic Analysis
2
Busulfan
2
Antilymphocyte Serum
2
thymoglobulin
1
peginterferon alfa-2a
1
flumatinib
1
fludarabine phosphate
1
Tyrosine Kinase Inhibitors
1
Therapeutics
1
Registries
1
Psychiatric Rehabilitation
1
Patient Reported Outcome Measures
1
PF-114
1
Mycophenolic Acid
1
Mitoxantrone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Pioglitazone
×
Clear all
NCT02889003
2018-03-22
PIO2STOP
Versailles Hospital
Phase 2
Unknown
26 enrolled
NCT02687425
2016-02-22
SESPI
Tongji Hospital
Phase 2
Unknown
20 enrolled